A correction to the age-adjustment of the GH-2000 score used in the detection of growth hormone misuse

Dankmar Böhning; Walailuck Böhning; Nishan Guha; David A. Cowan; Christiaan Bartlett; Peter H. Sönksen; Richard I.G. Holt

doi:10.1186/s13104-018-3741-7

A correction to the age-adjustment of the GH-2000 score used in the detection of growth hormone misuse

Dankmar Böhning^*, Walailuck Böhning, Nishan Guha, David A. Cowan, Christiaan Bartlett, Peter H. Sönksen, Richard I.G. Holt

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)

144 Downloads (Pure)

Abstract

Objective: The GH-2000 biomarker test has been introduced by the World Anti-Doping Agency as a method of detecting growth hormone misuse in professional sport. The test involves the measurement insulin-like growth factor-I and the amino-terminal pro-peptide of type III collagen (P-III-NP) which increase in a dose-dependent manner in response to GH. These measurements are combined in sex specific formulae that include an age adjustment. The original age adjustment overcorrects the effect of age in male athletes and could potentially place older men at a disadvantage. The purpose of this note is to investigate the performance of a previously suggested correction term in two new and larger data sets. Results: The GH-2000 score was calculated for 7307 samples obtained from 15 accredited WADA laboratories in 2017 and 3916 samples measured at Drug Control Centre, King's College London, UK between 2013 and 2017. The GH-2000 scores were investigated for positive age effects using standard regression modelling. As previously, all analyses confirmed a positive age effect. Applying the earlier suggested correction term of 0.032 × age showed a significant over-correction leading to a negative association of the GH-2000 score with age. We now suggest a smaller age correction of 0.020 × age, which corresponds to the smallest effect found in the earlier studies.

Original language	English
Article number	650
Journal	BMC Research Notes
Volume	11
Issue number	1
DOIs	https://doi.org/10.1186/s13104-018-3741-7
Publication status	Published - 5 Sept 2018

Keywords

Adjusting for age effects
Centring and norming of scores
GH-2000 score

Access to Document

10.1186/s13104-018-3741-7

A correction to the_Bohning_GOLD VoRFinal published version, 1.11 MB

Cite this

@article{ace45971a7784e44af4b27bb6d1e07a5,

title = "A correction to the age-adjustment of the GH-2000 score used in the detection of growth hormone misuse",

abstract = "Objective: The GH-2000 biomarker test has been introduced by the World Anti-Doping Agency as a method of detecting growth hormone misuse in professional sport. The test involves the measurement insulin-like growth factor-I and the amino-terminal pro-peptide of type III collagen (P-III-NP) which increase in a dose-dependent manner in response to GH. These measurements are combined in sex specific formulae that include an age adjustment. The original age adjustment overcorrects the effect of age in male athletes and could potentially place older men at a disadvantage. The purpose of this note is to investigate the performance of a previously suggested correction term in two new and larger data sets. Results: The GH-2000 score was calculated for 7307 samples obtained from 15 accredited WADA laboratories in 2017 and 3916 samples measured at Drug Control Centre, King's College London, UK between 2013 and 2017. The GH-2000 scores were investigated for positive age effects using standard regression modelling. As previously, all analyses confirmed a positive age effect. Applying the earlier suggested correction term of 0.032 × age showed a significant over-correction leading to a negative association of the GH-2000 score with age. We now suggest a smaller age correction of 0.020 × age, which corresponds to the smallest effect found in the earlier studies.",

keywords = "Adjusting for age effects, Centring and norming of scores, GH-2000 score",

author = "Dankmar B{\"o}hning and Walailuck B{\"o}hning and Nishan Guha and Cowan, {David A.} and Christiaan Bartlett and S{\"o}nksen, {Peter H.} and Holt, {Richard I.G.}",

year = "2018",

month = sep,

day = "5",

doi = "10.1186/s13104-018-3741-7",

language = "English",

volume = "11",

journal = "BMC Research Notes",

issn = "1756-0500",

publisher = "BioMed Central",

number = "1",

}

TY - JOUR

T1 - A correction to the age-adjustment of the GH-2000 score used in the detection of growth hormone misuse

AU - Böhning, Dankmar

AU - Böhning, Walailuck

AU - Guha, Nishan

AU - Cowan, David A.

AU - Bartlett, Christiaan

AU - Sönksen, Peter H.

AU - Holt, Richard I.G.

PY - 2018/9/5

Y1 - 2018/9/5

N2 - Objective: The GH-2000 biomarker test has been introduced by the World Anti-Doping Agency as a method of detecting growth hormone misuse in professional sport. The test involves the measurement insulin-like growth factor-I and the amino-terminal pro-peptide of type III collagen (P-III-NP) which increase in a dose-dependent manner in response to GH. These measurements are combined in sex specific formulae that include an age adjustment. The original age adjustment overcorrects the effect of age in male athletes and could potentially place older men at a disadvantage. The purpose of this note is to investigate the performance of a previously suggested correction term in two new and larger data sets. Results: The GH-2000 score was calculated for 7307 samples obtained from 15 accredited WADA laboratories in 2017 and 3916 samples measured at Drug Control Centre, King's College London, UK between 2013 and 2017. The GH-2000 scores were investigated for positive age effects using standard regression modelling. As previously, all analyses confirmed a positive age effect. Applying the earlier suggested correction term of 0.032 × age showed a significant over-correction leading to a negative association of the GH-2000 score with age. We now suggest a smaller age correction of 0.020 × age, which corresponds to the smallest effect found in the earlier studies.

AB - Objective: The GH-2000 biomarker test has been introduced by the World Anti-Doping Agency as a method of detecting growth hormone misuse in professional sport. The test involves the measurement insulin-like growth factor-I and the amino-terminal pro-peptide of type III collagen (P-III-NP) which increase in a dose-dependent manner in response to GH. These measurements are combined in sex specific formulae that include an age adjustment. The original age adjustment overcorrects the effect of age in male athletes and could potentially place older men at a disadvantage. The purpose of this note is to investigate the performance of a previously suggested correction term in two new and larger data sets. Results: The GH-2000 score was calculated for 7307 samples obtained from 15 accredited WADA laboratories in 2017 and 3916 samples measured at Drug Control Centre, King's College London, UK between 2013 and 2017. The GH-2000 scores were investigated for positive age effects using standard regression modelling. As previously, all analyses confirmed a positive age effect. Applying the earlier suggested correction term of 0.032 × age showed a significant over-correction leading to a negative association of the GH-2000 score with age. We now suggest a smaller age correction of 0.020 × age, which corresponds to the smallest effect found in the earlier studies.

KW - Adjusting for age effects

KW - Centring and norming of scores

KW - GH-2000 score

UR - http://www.scopus.com/inward/record.url?scp=85053150073&partnerID=8YFLogxK

U2 - 10.1186/s13104-018-3741-7

DO - 10.1186/s13104-018-3741-7

M3 - Article

AN - SCOPUS:85053150073

SN - 1756-0500

VL - 11

JO - BMC Research Notes

JF - BMC Research Notes

IS - 1

M1 - 650

ER -

A correction to the age-adjustment of the GH-2000 score used in the detection of growth hormone misuse

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this